Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris

A previously developed and centrally validated MammaPrint® (MP) and BluePrint® (BP) targeted RNA next-generation sequencing (NGS) kit was implemented and validated in two large academic European hospitals. Additionally, breast cancer molecular subtypes by MP and BP RNA sequencing were compared with...

Descripción completa

Detalles Bibliográficos
Autores principales: Slembrouck, Laurence, Darrigues, Lauren, Laurent, Cecile, Mittempergher, Lorenza, Delahaye, Leonie JMJ, Vanden Bempt, Isabelle, Vander Borght, Sara, Vliegen, Liesbet, Sintubin, Petra, Raynal, Virginie, Bohec, Mylene, Reyes, Cécile, Rapinat, Audrey, Helsmoortel, Céline, Jongen, Lynn, Hoste, Griet, Neven, Patrick, Wildiers, Hans, Smeets, Ann, Nevelsteen, Ines, Punie, Kevin, Van Nieuwenhuysen, Els, Han, Sileny, Vincent Salomon, Anne, Laas Faron, Enora, Cynober, Timothé, Gentien, David, Baulande, Sylvain, Snel, Mireille HJ, Witteveen, Anke T, Neijenhuis, Sari, Glas, Annuska M, Reyal, Fabien, Floris, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742807/
https://www.ncbi.nlm.nih.gov/pubmed/31513983
http://dx.doi.org/10.1016/j.tranon.2019.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742807/
https://www.ncbi.nlm.nih.gov/pubmed/31513983
http://dx.doi.org/10.1016/j.tranon.2019.08.008

Ejemplares similares